Gyanendra Nath Singh and Krishnaswamy VijayRaghavan were selected in the LSIPR 50 2017 publication for their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports.
Names: Gyanendra Nath Singh and Krishnaswamy VijayRaghavan
Organisation: Indian government
Positions: Drugs controller general, and secretary of the Department of Biotechnology
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
LSIPR 50 2017, Gyanendra Nath Singh, Krishnaswamy VijayRaghavan, Department of Biotechnolog, drugs, Indian government,